This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 May;87(5):525-7.

doi: 10.1038/clpt.2010.29.

The future is much closer collaboration between the pharmaceutical industry and academic medical centers

P Vallance¹, P Williams, C Dollery

Affiliations

PMID: 20407455
DOI: 10.1038/clpt.2010.29

Review

The future is much closer collaboration between the pharmaceutical industry and academic medical centers

P Vallance et al. Clin Pharmacol Ther. 2010 May.

. 2010 May;87(5):525-7.

doi: 10.1038/clpt.2010.29.

Authors

P Vallance¹, P Williams, C Dollery

Affiliation

¹ GlaxoSmithKline, London, UK.

PMID: 20407455
DOI: 10.1038/clpt.2010.29

No abstract available

PubMed Disclaimer

Comment in

Academic medical centers and the pharmaceutical industry.
Del Parigi A. Del Parigi A. Clin Pharmacol Ther. 2010 Oct;88(4):464-5. doi: 10.1038/clpt.2010.162. Epub 2010 Aug 11. Clin Pharmacol Ther. 2010. PMID: 20703224 No abstract available.

Similar articles

Pharma pursues novel models for academic collaboration.
Hughes B. Hughes B. Nat Rev Drug Discov. 2008 Aug;7(8):631-2. doi: 10.1038/nrd2648. Nat Rev Drug Discov. 2008. PMID: 18670424 No abstract available.
Can open-source drug R&D repower pharmaceutical innovation?
Munos B. Munos B. Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26. Clin Pharmacol Ther. 2010. PMID: 20407458 Review.
The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
Hoffmann T, Bishop C. Hoffmann T, et al. Drug Discov Today. 2010 Apr;15(7-8):260-4. doi: 10.1016/j.drudis.2010.02.002. Epub 2010 Feb 10. Drug Discov Today. 2010. PMID: 20149893
How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Perakslis ED, Van Dam J, Szalma S. Perakslis ED, et al. Clin Pharmacol Ther. 2010 May;87(5):614-6. doi: 10.1038/clpt.2010.21. Epub 2010 Apr 7. Clin Pharmacol Ther. 2010. PMID: 20376001 Review. No abstract available.
Demystifying industry-academia collaboration.
Gersdorf T, He VF, Schlesinger A, Koch G, Ehrismann D, Widmer H, von Krogh G. Gersdorf T, et al. Nat Rev Drug Discov. 2019 Sep;18(10):743-744. doi: 10.1038/d41573-019-00001-2. Nat Rev Drug Discov. 2019. PMID: 31570836 No abstract available.

See all similar articles

Cited by

Drug Discovery in Academia- the third way?
Frearson J, Wyatt P. Frearson J, et al. Expert Opin Drug Discov. 2010 Oct 1;5(10):909-19. doi: 10.1517/17460441.2010.506508. Expert Opin Drug Discov. 2010. PMID: 20922062 Free PMC article.
Helping science and drug development to succeed through pharma-academia partnerships: Yale Healthcare Conference 2013.
Yang DX, Kim YA. Yang DX, et al. Yale J Biol Med. 2013 Sep 20;86(3):429-32. eCollection 2013 Sep. Yale J Biol Med. 2013. PMID: 24058318 Free PMC article.
The landscape of biomedical research funding in Brazil: a current overview.
Gomes CM, Marchini G, de Bessa J Júnior, Carvalhal G, Caldeira MPR, Saldiva PH, Krieger JE, Agena F, Reis S, Paschoal C, Froes M, Srougi M, Nahas WC, Favorito LA. Gomes CM, et al. Int Braz J Urol. 2024 Mar-Apr;50(2):209-222. doi: 10.1590/S1677-5538.IBJU.2024.9905. Int Braz J Urol. 2024. PMID: 38386791 Free PMC article. Review.
Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed.
Simeon-Dubach D, Roehrl MH, Hofman P, Puchois P. Simeon-Dubach D, et al. Biopreserv Biobank. 2020 Apr;18(2):144-149. doi: 10.1089/bio.2019.0095. Epub 2020 Feb 11. Biopreserv Biobank. 2020. PMID: 32043910 Free PMC article. No abstract available.
Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.
Dong Y, Nakagawa-Goto K, Lai CY, Morris-Natschke SL, Bastow KF, Lee KH. Dong Y, et al. Bioorg Med Chem Lett. 2011 Jan 1;21(1):546-9. doi: 10.1016/j.bmcl.2010.10.074. Epub 2010 Nov 17. Bioorg Med Chem Lett. 2011. PMID: 21087859 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley